Evidence map›Paper›PMID 34510910›Full record

ArticleACS biomaterials science & engineering2021

Self-Assembled, Dilution-Responsive Hydrogels for Enhanced Thermal Stability of Insulin Biopharmaceuticals.

Catherine M Meis, Erika E Salzman, Caitlin L Maikawa, Anton A A Smith, Joseph L Mann, Abigail K Grosskopf, Eric A Appel

Open access · hybridAbstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.The Journal of clinical endocrinology and metabolism · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Catherine M MeisDepartment of Materials Science & Engineering, Stanford University, 496 Lomita Mall, Stanford, California 94305, United States.
Erika E SalzmanDepartment of Materials Science & Engineering, Stanford University, 496 Lomita Mall, Stanford, California 94305, United States.
Caitlin L MaikawaDepartment of Bioengineering, Stanford University, 443 Via Ortega, Stanford, California 94305, United States.
Anton A A SmithDepartment of Materials Science & Engineering, Stanford University, 496 Lomita Mall, Stanford, California 94305, United States.
Joseph L MannDepartment of Materials Science & Engineering, Stanford University, 496 Lomita Mall, Stanford, California 94305, United States.
Abigail K GrosskopfDepartment of Chemical Engineering, Stanford University, 443 Via Ortega, Stanford, California 94305, United States.
Eric A AppelDepartment of Materials Science & Engineering, Stanford University, 496 Lomita Mall, Stanford, California 94305, United States.ORCID 0000-0002-2301-7126
Stanford University · USAarhus University · DK

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Co-Formulations of Amylin Analogues with Insulin Analogues for Treatment of DiabetesR01DK119254 · NIDDK · STANFORD UNIVERSITY · PI APPEL, ERIC ANDREW · 2019 to 2023
$2.9M
NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK119254
6 · The paper itself

Abstract

Biotherapeutics currently dominate the landscape of new drugs because of their exceptional potency and selectivity. Yet, the intricate molecular structures that give rise to these beneficial qualities also render them unstable in formulation. Hydrogels have shown potential as stabilizing excipients for biotherapeutic drugs, providing protection against harsh thermal conditions experienced during distribution and storage. In this work, we report the utilization of a cellulose-based supramolecular hydrogel formed from polymer-nanoparticle (PNP) interactions to encapsulate and stabilize insulin, an important biotherapeutic used widely to treat diabetes. Encapsulation of insulin in these hydrogels prevents insulin aggregation and maintains insulin bioactivity through stressed aging conditions of elevated temperature and continuous agitation for over 28 days. Further, insulin can be easily recovered by dilution of these hydrogels for administration at the point of care. This supramolecular hydrogel system shows promise as a stabilizing excipient to reduce the cold chain dependence of insulin and other biotherapeutics.

Indexed as

Biological ProductsNanoparticlesHydrogelsInsulinPolymersBiological ProductsHydrogelsInsulinPolymersbiomaterialsbiotherapeuticcold chaindrug deliveryhydrogelsupramolecular

Identifiers

PMID34510910
PMCPMC8441967
OpenAlexW3103707491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.